Skip to main content
Top
Published in: International Cancer Conference Journal 2/2018

01-04-2018 | Case Report

Malignant triton tumor of the duodenum: report of a case

Authors: Yoh Asahi, Takahito Nakagawa, Katsuya Nakanishi, Tomofumi Takagi, Hiroyuki Yoshikawa, Kazuki Wakizaka, Ryoji Yokoyama, Manabu Takahashi, Fumiaki Sasaki

Published in: International Cancer Conference Journal | Issue 2/2018

Login to get access

Abstract

We report a case of malignant triton tumor of the duodenum, which is extremely rare. A submucosal malignant tumor was detected in the duodenum of a 49-year-old woman. The tumor was completely resected by performing pancreaticoduodenectomy. Pathological examination revealed that the lesion was a malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation, i.e., a malignant triton tumor. Long-term survival has been achieved with no recurrence at 8.5 years after surgery.
Literature
1.
go back to reference Guo A, Liu A, Wei L et al (2012) Malignant peripheral nerve sheath tumors: differentiation patterns and immunohistochemical features—a mini-review and our new findings. J Cancer 3:303–309CrossRefPubMedPubMedCentral Guo A, Liu A, Wei L et al (2012) Malignant peripheral nerve sheath tumors: differentiation patterns and immunohistochemical features—a mini-review and our new findings. J Cancer 3:303–309CrossRefPubMedPubMedCentral
2.
go back to reference Kolberg M, Høland M, Agesen TH et al (2013) Survival meta-analyses for> 1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro Oncol 15:135–147CrossRefPubMed Kolberg M, Høland M, Agesen TH et al (2013) Survival meta-analyses for> 1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro Oncol 15:135–147CrossRefPubMed
3.
go back to reference Ducatman BS, Scheithauer BW, Piepgras DG et al (1986) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006–2021CrossRefPubMed Ducatman BS, Scheithauer BW, Piepgras DG et al (1986) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006–2021CrossRefPubMed
4.
go back to reference Woodruff JM, Chernik NL, Smith MC et al (1973) Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant ‘Triton’ tumors). Cancer 32:426–439CrossRefPubMed Woodruff JM, Chernik NL, Smith MC et al (1973) Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant ‘Triton’ tumors). Cancer 32:426–439CrossRefPubMed
5.
go back to reference Yamamoto T, Minami R, Ohbayashi C (2001) Subcutaneous malignant epithelioid schwannoma with cartilaginous differentiation. J Cutan Pathol 28:486–491CrossRefPubMed Yamamoto T, Minami R, Ohbayashi C (2001) Subcutaneous malignant epithelioid schwannoma with cartilaginous differentiation. J Cutan Pathol 28:486–491CrossRefPubMed
6.
go back to reference Rodriguez FJ, Scheithauer BW, Abell-Aleff PC et al (2007) Low grade malignant peripheral nerve sheath tumor with smooth muscle differentiation. Acta Neuropathol 113:705–709CrossRefPubMed Rodriguez FJ, Scheithauer BW, Abell-Aleff PC et al (2007) Low grade malignant peripheral nerve sheath tumor with smooth muscle differentiation. Acta Neuropathol 113:705–709CrossRefPubMed
7.
go back to reference Suresh TN, Harendra Kumar ML, Prasad CS et al (2009) Malignant peripheral nerve sheath tumor with divergent differentiation. Indian J Pathol Microbiol 52:74–761CrossRefPubMed Suresh TN, Harendra Kumar ML, Prasad CS et al (2009) Malignant peripheral nerve sheath tumor with divergent differentiation. Indian J Pathol Microbiol 52:74–761CrossRefPubMed
8.
go back to reference Masson P (1932) Recklinghausen’s neurofibromatosis, sensory neuromas and motor neuromas. Libman Anniversary, vol 2. The International Press, New York, pp 793–802 Masson P (1932) Recklinghausen’s neurofibromatosis, sensory neuromas and motor neuromas. Libman Anniversary, vol 2. The International Press, New York, pp 793–802
9.
go back to reference Li G, Liu C, Liu Y et al (2015) Analysis of clinical features and prognosis of malignant triton tumor: a report of two cases and literature review. Oncol Lett 10:3551–3556CrossRefPubMedPubMedCentral Li G, Liu C, Liu Y et al (2015) Analysis of clinical features and prognosis of malignant triton tumor: a report of two cases and literature review. Oncol Lett 10:3551–3556CrossRefPubMedPubMedCentral
10.
go back to reference Lee YJ, Moon HG, Park ST et al (2006) Malignant peripheral nerve sheath tumor arising from the colon in a newborn: report of a case and review of the literatures. J Pediatr Surg 41:e19–e22 Lee YJ, Moon HG, Park ST et al (2006) Malignant peripheral nerve sheath tumor arising from the colon in a newborn: report of a case and review of the literatures. J Pediatr Surg 41:e19–e22
11.
go back to reference Stucky CC, Johnson KN, Gray RJ et al (2012) Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol 19:878–885CrossRefPubMed Stucky CC, Johnson KN, Gray RJ et al (2012) Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol 19:878–885CrossRefPubMed
12.
go back to reference Wong WW, Hirose T, Scheithauer BW et al (1998) Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 42:351–360CrossRefPubMed Wong WW, Hirose T, Scheithauer BW et al (1998) Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 42:351–360CrossRefPubMed
13.
go back to reference Riccardi VM, Powell PP (1989) Neurofibrosarcoma as a complication of von Recklinghausen neurofibromatosis. Neurofibromatosis 2:152–165PubMed Riccardi VM, Powell PP (1989) Neurofibrosarcoma as a complication of von Recklinghausen neurofibromatosis. Neurofibromatosis 2:152–165PubMed
14.
go back to reference Neville H, Corpron C, Blakely ML et al (2003) Pediatric neurofibrosarcoma. J Pediatr Surg 38:343–346CrossRefPubMed Neville H, Corpron C, Blakely ML et al (2003) Pediatric neurofibrosarcoma. J Pediatr Surg 38:343–346CrossRefPubMed
15.
go back to reference Ferner RE, Huson SM, Thomas N et al (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81–88CrossRefPubMed Ferner RE, Huson SM, Thomas N et al (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81–88CrossRefPubMed
16.
go back to reference Brooks JS, Freeman M, Enterline HT (1985) Malignant “Triton” tumors. Natural history and immunohistochemistry of nine new cases with literature review. Cancer 55:2543–2549CrossRefPubMed Brooks JS, Freeman M, Enterline HT (1985) Malignant “Triton” tumors. Natural history and immunohistochemistry of nine new cases with literature review. Cancer 55:2543–2549CrossRefPubMed
17.
go back to reference Nistche M, Reible M, Pflüger KH et al (2014) Malignant triton tumor of the sciatic nerve as a secondary malignancy after extended field radiotherapy and chemotherapy of Hodgkin’s disease. Case Rep Oncol 7:239–245CrossRef Nistche M, Reible M, Pflüger KH et al (2014) Malignant triton tumor of the sciatic nerve as a secondary malignancy after extended field radiotherapy and chemotherapy of Hodgkin’s disease. Case Rep Oncol 7:239–245CrossRef
18.
go back to reference Omar T, Raslan H, EI Sheikh S et al (2014) Low-grade malignant triton tumor of the neck: a case report and review of the literature. Case Rep Pathol 2014:674094PubMedPubMedCentral Omar T, Raslan H, EI Sheikh S et al (2014) Low-grade malignant triton tumor of the neck: a case report and review of the literature. Case Rep Pathol 2014:674094PubMedPubMedCentral
19.
go back to reference Schaefer IM, Fletcher CD, Fomick JL (2015) Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Mod Pathol 29:4–13CrossRefPubMed Schaefer IM, Fletcher CD, Fomick JL (2015) Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Mod Pathol 29:4–13CrossRefPubMed
20.
go back to reference Prieto-Granada CN, Wiesner T, Messina JL et al (2016) Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST. Am J Surg Pathol 40:479–489CrossRefPubMedPubMedCentral Prieto-Granada CN, Wiesner T, Messina JL et al (2016) Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST. Am J Surg Pathol 40:479–489CrossRefPubMedPubMedCentral
21.
go back to reference Marano L, Boccardi V, Marrelli D et al (2015) Duodenal gastrointestinal stromal tumor: from clinicopathological features to surgical outcomes. Eur J Surg Oncol 41:814–822CrossRefPubMed Marano L, Boccardi V, Marrelli D et al (2015) Duodenal gastrointestinal stromal tumor: from clinicopathological features to surgical outcomes. Eur J Surg Oncol 41:814–822CrossRefPubMed
22.
go back to reference Okabayashi T, Shima Y, Iwata J et al (2013) Primary liposarcoma of the duodenum: a first case presentation. Intern Med 52:2753–2757CrossRefPubMed Okabayashi T, Shima Y, Iwata J et al (2013) Primary liposarcoma of the duodenum: a first case presentation. Intern Med 52:2753–2757CrossRefPubMed
23.
go back to reference West RB, Coriess CL, Chen X et al (2004) The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165:107–113CrossRefPubMedPubMedCentral West RB, Coriess CL, Chen X et al (2004) The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165:107–113CrossRefPubMedPubMedCentral
24.
go back to reference Binh MB, Sastre-Garau X, Guillou L et al (2005) MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 29:1340–1347CrossRefPubMed Binh MB, Sastre-Garau X, Guillou L et al (2005) MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 29:1340–1347CrossRefPubMed
25.
go back to reference Daimaru Y, Hashimoto H, Enjpji M (1984) Malignant “triton” tumors: a clinicopathologic and immunohistochemical study of nine cases. Hum Pathol 15:768–778CrossRefPubMed Daimaru Y, Hashimoto H, Enjpji M (1984) Malignant “triton” tumors: a clinicopathologic and immunohistochemical study of nine cases. Hum Pathol 15:768–778CrossRefPubMed
26.
go back to reference Rekhi B, Jambhekar NA, Puri A et al (2008) Clinicomorphologic features of a series of 10 cases of malignant triton tumors diagnosed over 10 years at a tertiary cancer hospital in Mumbai, India. Ann Diag Pathol 12:90–97CrossRef Rekhi B, Jambhekar NA, Puri A et al (2008) Clinicomorphologic features of a series of 10 cases of malignant triton tumors diagnosed over 10 years at a tertiary cancer hospital in Mumbai, India. Ann Diag Pathol 12:90–97CrossRef
27.
go back to reference Clapp WA, Haas R (1971) Neurofibrosarcoma of the duodenum. J Maine Med Assoc 62:55–56PubMed Clapp WA, Haas R (1971) Neurofibrosarcoma of the duodenum. J Maine Med Assoc 62:55–56PubMed
28.
go back to reference Thomson WO, Carachi R, Wood CB et al (1979) Neurofibrosarcoma of the duodenum in von Recklinghausen’s disease. Br J Surg 66:29–30CrossRefPubMed Thomson WO, Carachi R, Wood CB et al (1979) Neurofibrosarcoma of the duodenum in von Recklinghausen’s disease. Br J Surg 66:29–30CrossRefPubMed
29.
go back to reference Melissas J, Schoretsanitis G, Valasiadou K et al (1995) Neurofibrosarcoma of the duodenum. Eur J Surg Oncol 21:571–572CrossRefPubMed Melissas J, Schoretsanitis G, Valasiadou K et al (1995) Neurofibrosarcoma of the duodenum. Eur J Surg Oncol 21:571–572CrossRefPubMed
30.
go back to reference Tanaka N, Nobori M, Furuya T et al (1997) Solitary malignant schwannoma of the duodenum with metastasis to the liver: report of a case. Surg Today Jpn J Surg 27:1173–1176CrossRef Tanaka N, Nobori M, Furuya T et al (1997) Solitary malignant schwannoma of the duodenum with metastasis to the liver: report of a case. Surg Today Jpn J Surg 27:1173–1176CrossRef
31.
go back to reference Wanebo JE, Malik JM, VandenBerg SR et al (1993) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer 71:1247–1253CrossRefPubMed Wanebo JE, Malik JM, VandenBerg SR et al (1993) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer 71:1247–1253CrossRefPubMed
32.
go back to reference Sordillo PP, Helson L, Hajdu SI et al (1981) Malignant schwannoma—clinical characteristics, survival, and response to therapy. Cancer 47:2503–2509CrossRefPubMed Sordillo PP, Helson L, Hajdu SI et al (1981) Malignant schwannoma—clinical characteristics, survival, and response to therapy. Cancer 47:2503–2509CrossRefPubMed
33.
go back to reference McConnell YJ, Giacomantonio CA (2012) Malignant triton tumors—complete surgical resection and adjuvant radiotherapy associated with improved survival. J Surg Oncol 106:51–56CrossRefPubMed McConnell YJ, Giacomantonio CA (2012) Malignant triton tumors—complete surgical resection and adjuvant radiotherapy associated with improved survival. J Surg Oncol 106:51–56CrossRefPubMed
34.
go back to reference Kahn J, Gillespie A, Tsokos M et al (2014) Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Front Oncol 4:324CrossRefPubMedPubMedCentral Kahn J, Gillespie A, Tsokos M et al (2014) Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Front Oncol 4:324CrossRefPubMedPubMedCentral
Metadata
Title
Malignant triton tumor of the duodenum: report of a case
Authors
Yoh Asahi
Takahito Nakagawa
Katsuya Nakanishi
Tomofumi Takagi
Hiroyuki Yoshikawa
Kazuki Wakizaka
Ryoji Yokoyama
Manabu Takahashi
Fumiaki Sasaki
Publication date
01-04-2018
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 2/2018
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-0320-7

Other articles of this Issue 2/2018

International Cancer Conference Journal 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine